Medpace Holdings, Inc. SEC filings MEDP
Medpace Holdings, Inc. has 930 filings in SEC EDGAR's recent list, going back to Mar 15, 2016. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 22, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 1, 2026 | — |
| DEF 14A | Proxy statement | Apr 1, 2026 | May 15, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 16, 2026 | May 15, 2026 |
| DEFA14A | Additional proxy material | Apr 2, 2025 | — |
| DEF 14A | Proxy statement | Apr 2, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 17, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2024 | May 17, 2024 |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 5, 2023 | — |
| DEFA14A | Additional proxy material | Apr 6, 2022 | — |
| DEF 14A | Proxy statement | Apr 6, 2022 | May 20, 2022 |
| DEFA14A | Additional proxy material | Mar 30, 2021 | — |
| DEF 14A | Proxy statement | Mar 30, 2021 | May 14, 2021 |
| DEFA14A | Additional proxy material | Apr 1, 2020 | — |
| DEF 14A | Proxy statement | Apr 1, 2020 | May 15, 2020 |
| DEFA14A | Additional proxy material | Apr 3, 2019 | — |
| DEF 14A | Proxy statement | Apr 3, 2019 | May 17, 2019 |
| DEFA14A | Additional proxy material | Apr 5, 2018 | — |
| DEF 14A | Proxy statement | Apr 5, 2018 | May 18, 2018 |
| DEFA14A | Additional proxy material | Apr 5, 2017 | — |
| DEF 14A | Proxy statement | Apr 5, 2017 | May 19, 2017 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- MEDP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1668397
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.